Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$575.13
At close: Nov 8, 9:29 AM EDT
$575.27
0.140.02%
After Hours: Nov 8, 9:29 AM EDT
Comments
Loading...
GE Vernova Analyst Ratings and Price Targets | NYSE:GEV | Benzinga
GE Vernova Inc has a consensus price target of $613.08 based on the ratings of 27 analysts. The high is $758 issued by GLJ Research on October 15, 2025. The low is $336 issued by Daiwa Capital on October 30, 2024. The 3 most-recent analyst ratings were released by Morgan Stanley, Wells Fargo, and Mizuho on October 30, 2025, October 24, 2025, and October 24, 2025, respectively. With an average price target of $695.67 between Morgan Stanley, Wells Fargo, and Mizuho, there's an implied 20.93% upside for GE Vernova Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
Wells Fargo
Mizuho
JP Morgan
TD Cowen
1calculated from analyst ratings
Analyst Ratings for GE Vernova
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/30/2025 | 23.42% | Morgan Stanley | $690 → $710 | Maintains | Overweight | |||
10/24/2025 | 24.64% | Wells Fargo | $697 → $717 | Maintains | Overweight | |||
10/24/2025 | 14.73% | Mizuho | $677 → $660 | Maintains | Neutral | |||
10/23/2025 | 28.64% | JP Morgan | $715 → $740 | Maintains | Overweight | |||
10/23/2025 | 18.21% | TD Cowen | $685 → $680 | Maintains | Buy | |||
10/23/2025 | 30.37% | Susquehanna | $740 → $750 | Maintains | Positive | |||
10/23/2025 | 9.51% | RBC Capital | $605 → $630 | Maintains | Sector Perform | |||
10/23/2025 | 23.42% | BMO Capital | $690 → $710 | Maintains | Outperform | |||
10/23/2025 | 23.42% | Barclays | $706 → $710 | Maintains | Overweight | |||
10/23/2025 | 14.38% | Citigroup | $670 → $658 | Maintains | Neutral | |||
10/16/2025 | 19.94% | Morgan Stanley | $675 → $690 | Maintains | Overweight | |||
10/15/2025 | 31.76% | GLJ Research | $702 → $758 | Maintains | Buy | |||
10/15/2025 | 17.68% | Mizuho | $670 → $677 | Maintains | Neutral | |||
10/15/2025 | -17.43% | Rothschild & Co | → $475 | Downgrade | Neutral → Sell | |||
10/13/2025 | 28.64% | Susquehanna | $736 → $740 | Maintains | Positive | |||
09/15/2025 | 28.64% | Melius Research | → $740 | Upgrade | Hold → Buy | |||
09/12/2025 | 16.12% | Jefferies | $658 → $668 | Maintains | Hold | |||
09/05/2025 | 0.82% | HSBC | $570 → $580 | Maintains | Hold | |||
08/15/2025 | 14.38% | Jefferies | $620 → $658 | Maintains | Hold | |||
07/24/2025 | 16.47% | Citigroup | $544 → $670 | Maintains | Neutral | |||
07/24/2025 | 19.94% | BMO Capital | $590 → $690 | Maintains | Outperform | |||
07/24/2025 | 24.29% | JP Morgan | $620 → $715 | Maintains | Overweight | |||
07/24/2025 | 27.94% | Susquehanna | $662 → $736 | Maintains | Positive | |||
07/24/2025 | 21.16% | Wells Fargo | $474 → $697 | Maintains | Overweight | |||
07/24/2025 | 17.34% | Morgan Stanley | $511 → $675 | Maintains | Overweight | |||
07/24/2025 | 22.72% | Barclays | $580 → $706 | Maintains | Overweight | |||
07/24/2025 | 22.72% | Baird | $568 → $706 | Maintains | Outperform | |||
07/17/2025 | 7.78% | B of A Securities | $550 → $620 | Maintains | Buy | |||
07/16/2025 | 7.78% | JP Morgan | $460 → $620 | Maintains | Overweight | |||
07/14/2025 | -5.44% | Citigroup | $354 → $544 | Maintains | Neutral | |||
07/10/2025 | 9.51% | Seaport Global | → $630 | Initiates | → Buy | |||
07/09/2025 | 0.82% | Barclays | $550 → $580 | Maintains | Overweight | |||
07/08/2025 | 2.56% | BMO Capital | $522 → $590 | Maintains | Outperform | |||
07/07/2025 | 6.73% | UBS | → $614 | Initiates | → Buy | |||
06/24/2025 | -11.17% | Morgan Stanley | $422 → $511 | Maintains | Overweight | |||
06/23/2025 | 22.03% | GLJ Research | → $702 | Initiates | → Buy | |||
06/13/2025 | — | Wolfe Research | — | Downgrade | Outperform → Peer Perform | |||
06/11/2025 | -4.39% | B of A Securities | $520 → $550 | Maintains | Buy | |||
06/10/2025 | -0.92% | Goldman Sachs | $500 → $570 | Maintains | Buy | |||
06/09/2025 | -4.39% | Barclays | $500 → $550 | Maintains | Overweight | |||
05/30/2025 | -9.26% | BMO Capital | $381 → $522 | Maintains | Outperform | |||
05/30/2025 | -13.08% | Barclays | $427 → $500 | Maintains | Overweight | |||
05/29/2025 | -10.13% | Jefferies | $427 → $517 | Downgrade | Buy → Hold | |||
05/16/2025 | -20.04% | JP Morgan | $430 → $460 | Maintains | Overweight | |||
05/14/2025 | -13.26% | Susquehanna | $399 → $499 | Maintains | Positive | |||
04/25/2025 | -25.77% | Jefferies | $418 → $427 | Maintains | Buy | |||
04/24/2025 | -33.94% | Guggenheim | $380 → $380 | Reiterates | Buy → Buy | |||
04/24/2025 | -26.64% | Morgan Stanley | $400 → $422 | Maintains | Overweight | |||
04/24/2025 | -30.64% | Susquehanna | $370 → $399 | Maintains | Positive | |||
04/24/2025 | -29.6% | Baird | $387 → $405 | Maintains | Outperform | |||
04/23/2025 | -25.25% | JP Morgan | $425 → $430 | Maintains | Overweight | |||
04/17/2025 | -27.34% | Jefferies | $413 → $418 | Maintains | Buy | |||
04/17/2025 | -33.94% | Guggenheim | $380 → $380 | Reiterates | Buy → Buy | |||
04/15/2025 | -32.73% | Baird | $448 → $387 | Maintains | Outperform | |||
04/14/2025 | -38.46% | Citigroup | $437 → $354 | Maintains | Neutral | |||
04/10/2025 | -26.12% | JP Morgan | $436 → $425 | Maintains | Overweight | |||
04/09/2025 | -33.77% | BMO Capital | $420 → $381 | Maintains | Outperform | |||
04/02/2025 | -35.68% | Susquehanna | → $370 | Initiates | → Positive | |||
03/27/2025 | -28.21% | Jefferies | $391 → $413 | Maintains | Buy | |||
03/18/2025 | -22.65% | RBC Capital | $453 → $445 | Maintains | Outperform | |||
03/05/2025 | -33.94% | Guggenheim | → $380 | Upgrade | Neutral → Buy | |||
03/03/2025 | -26.99% | BMO Capital | $471 → $420 | Maintains | Outperform | |||
03/03/2025 | -25.77% | Barclays | $487 → $427 | Maintains | Overweight | |||
02/19/2025 | — | CICC | — | Initiates | → Outperform | |||
02/13/2025 | -22.12% | Baird | → $448 | Initiates | → Outperform | |||
02/07/2025 | -26.12% | Johnson Rice | → $425 | Initiates | → Buy | |||
01/28/2025 | -21.25% | RBC Capital | $453 → $453 | Reiterates | Outperform → Outperform | |||
01/24/2025 | -33.94% | Guggenheim | $380 → $380 | Downgrade | Buy → Neutral | |||
01/24/2025 | -13.08% | Goldman Sachs | $446 → $500 | Maintains | Buy | |||
01/23/2025 | -18.3% | Truist Securities | $420 → $470 | Maintains | Buy | |||
01/23/2025 | -18.13% | BMO Capital | $420 → $471 | Maintains | Outperform | |||
01/23/2025 | -24.04% | Citigroup | $361 → $437 | Maintains | Neutral | |||
01/23/2025 | -15.34% | Barclays | $420 → $487 | Maintains | Overweight | |||
01/23/2025 | -24.21% | JP Morgan | $374 → $436 | Maintains | Overweight | |||
01/21/2025 | -26.99% | BMO Capital | $360 → $420 | Maintains | Outperform | |||
01/21/2025 | -9.61% | B of A Securities | $415 → $520 | Reiterates | Buy → Buy | |||
01/16/2025 | -22.47% | Goldman Sachs | $400 → $446 | Maintains | Buy | |||
01/16/2025 | -26.99% | Truist Securities | $400 → $420 | Maintains | Buy | |||
01/14/2025 | -27.86% | B of A Securities | $380 → $415 | Maintains | Buy | |||
01/14/2025 | -34.99% | JP Morgan | $367 → $374 | Maintains | Overweight | |||
12/13/2024 | -28.56% | Wells Fargo | $385 → $411 | Maintains | Overweight | |||
12/13/2024 | -32.03% | Jefferies | $348 → $391 | Maintains | Buy | |||
12/12/2024 | -30.47% | Goldman Sachs | $324 → $400 | Maintains | Buy | |||
12/11/2024 | -36.2% | JP Morgan | $356 → $367 | Maintains | Overweight | |||
12/11/2024 | -32.21% | Evercore ISI Group | $385 → $390 | Maintains | Outperform | |||
12/11/2024 | -33.94% | Guggenheim | $400 → $380 | Maintains | Buy | |||
12/11/2024 | -34.64% | RBC Capital | $376 → $376 | Reiterates | Outperform → Outperform | |||
12/10/2024 | -30.47% | Truist Securities | $325 → $400 | Maintains | Buy | |||
12/09/2024 | -37.25% | Citigroup | $292 → $361 | Maintains | Neutral | |||
12/05/2024 | -26.99% | Barclays | $320 → $420 | Maintains | Overweight | |||
12/05/2024 | -30.47% | Guggenheim | $300 → $400 | Maintains | Buy | |||
12/04/2024 | -29.95% | Wolfe Research | → $403 | Initiates | → Outperform | |||
12/03/2024 | -38.12% | JP Morgan | $330 → $356 | Maintains | Overweight | |||
11/25/2024 | -34.64% | RBC Capital | $285 → $376 | Maintains | Outperform | |||
11/21/2024 | -33.07% | Wells Fargo | → $385 | Initiates | → Overweight | |||
11/15/2024 | -36.2% | Morgan Stanley | $301 → $367 | Maintains | Overweight | |||
10/30/2024 | -41.59% | Daiwa Capital | $245 → $336 | Upgrade | Outperform → Buy | |||
10/24/2024 | -43.5% | Truist Securities | $300 → $325 | Maintains | Buy | |||
10/24/2024 | -47.68% | Morgan Stanley | $256 → $301 | Maintains | Overweight | |||
10/24/2024 | -50.46% | RBC Capital | $262 → $285 | Maintains | Outperform |
FAQ
What is the target price for GE Vernova (GEV) stock?
The latest price target for GE Vernova (NYSE:GEV) was reported by Morgan Stanley on October 30, 2025. The analyst firm set a price target for $710.00 expecting GEV to rise to within 12 months (a possible 23.42% upside). 96 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for GE Vernova (GEV)?
The latest analyst rating for GE Vernova (NYSE:GEV) was provided by Morgan Stanley, and GE Vernova maintained their overweight rating.
When was the last upgrade for GE Vernova (GEV)?
The last upgrade for GE Vernova Inc happened on September 15, 2025 when Melius Research raised their price target to $740. Melius Research previously had a hold for GE Vernova Inc.
When was the last downgrade for GE Vernova (GEV)?
The last downgrade for GE Vernova Inc happened on October 15, 2025 when Rothschild & Co changed their price target from N/A to $475 for GE Vernova Inc.
When is the next analyst rating going to be posted or updated for GE Vernova (GEV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GE Vernova, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GE Vernova was filed on October 30, 2025 so you should expect the next rating to be made available sometime around October 30, 2026.
Is the Analyst Rating GE Vernova (GEV) correct?
While ratings are subjective and will change, the latest GE Vernova (GEV) rating was a maintained with a price target of $690.00 to $710.00. The current price GE Vernova (GEV) is trading at is $575.27, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
